Digital Innovation in Healthcare: Software R&D & Tax C...
Transforming Healthcare innovation Through Technology The healthcare sector is undergoing a profo...

With the R&D tax credit Deadline 2026 fast approaching, many businesses risk leaving money on the table simply because they are unaware of the key dates that apply to them.
2025 was a year full of significant legislative updates and tax code changes, many of which impacted Leyton’s services in areas such as the Credit for Increasing Research Activities (R&D Credit), federal and state Grant Incentives, State and Local Tax, and Commercial Real Estate incentives such as the 179D deduction or 45L tax credit.
In case you missed it, see our year-end webinar here for more detail on these changes within each of these areas.
The rest of this article applies specifically to important dates and deadlines related to the R&D tax Credit, as we enter the new calendar and tax years.
March 16th (Monday):
April 15th (Wednesday):
Forms 7004, which enable returns to be filed on extension, must be filed by the entity’s applicable timely filing deadline listed above. Extensions push the original return due date by six months.
The R&D Credit can be claimed retroactively, up to three tax years prior, depending on past returns’ original filing dates and the statute of limitations. Currently, for example a company may be able to claim the credit as far back as tax year 2022, assuming it is a calendar-year filer.
Tax year 2022 (TY25 minus three years) will be used to illustrate the statute below:
Another major impact of the One Big Beautiful Bill (OBBB) and subsequent Rev Proc. 2025-28 was to allow for ‘retroactive relief’ of the previous requirement to capitalize domestic-based R&D costs.
See our past articles on the OBBB and Rev Proc. 2025-28 for more detailed guidance on these updates. Essentially, eligible small businesses can amend tax years 2022 – 2024 to claim the credit without capitalizing R&D costs. If R&D costs were capitalized on original returns, they can be amended to reinstate full expensing of such costs.
The deadline to amend these returns and avoid capitalizing R&D costs is 7/6/2026 for all tax years, 2022 – 2024.
There is no need to capitalize domestic R&D costs in tax years 2025 and onward, per the OBBB. For purposes of the retroactive relief, companies qualify as eligible small businesses if their average gross receipts from 2022–2024 are under $30M per year. If companies would rather forego amending returns, all remaining amortization expense of R&D costs can be accelerated:
These dates are extremely important, as companies can lose out on five to six-figure credit amounts that they are entitled to, simply due to missing an amendment deadline.
We always recommend that the R&D credit claim is included in a company’s original return filing, to avoid amendments and the associated costs and waiting period.
As the IRS’ workforce continues to decrease (25% just in calendar year 2025), the waiting period for amended returns processing and associated refunds can be several months to over a year.
To facilitate including the R&D Form in timely-filed returns, we recommend that the R&D study starts at least a month and a half prior to a company’s filing deadline in 2026.
The R&D study entails technical interviews, data gathering of both financial and technical support documents, and a thorough analysis of qualified costs and their nexus to qualified projects.
Leyton’s process also entails a detailed internal QC review & generation of a Technical Report, which serves to substantiate all activities and costs being qualified for the credit.
Explore our latest insights
See more arrow_forward
Transforming Healthcare innovation Through Technology The healthcare sector is undergoing a profo...

For more than a decade, the 179D Energy Efficient Commercial Buildings Deduction has been a meani...

In the world of pharmaceuticals and biotechnology, innovation isn’t optional; it’s the foundation...

Sales tax exemption certificates are a common compliance tool businesses use to avoid paying sale...